Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 107201-107250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03848312
Preventing Alzheimer's With Cognitive Training
PHASE3
Recruiting
7,600 participants
Started: Feb 19, 2019 · Completed: Jan 31, 2026
2 conditions
2 sponsors
7 locations
NCT03825523
Immediate ART in Subjects with Opportunistic Diseases
NA
Active, not recruiting
114 participants
Started: Feb 18, 2019 · Completed: Sep 1, 2025
2 conditions
1 sponsor
1 location
NCT03425565
A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer
PHASE2
Active, not recruiting
48 participants
Started: Feb 18, 2019 · Completed: Sep 30, 2024
3 conditions
1 sponsor
5 locations
NCT03858244
Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children
N/A
Active, not recruiting
352 participants
Started: Feb 18, 2019 · Completed: Mar 1, 2025
3 conditions
5 sponsors
1 location
NCT03737461
Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive
PHASE2/PHASE3
Active, not recruiting
113 participants
Started: Feb 18, 2019 · Completed: Mar 8, 2026
2 conditions
17 sponsors
9 locations
NCT03673800
Cognitive Control Training in Online Problem Gambling
NA
Active, not recruiting
200 participants
Started: Feb 18, 2019 · Completed: Mar 31, 2024
1 condition
2 sponsors
1 location
NCT03968744
Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease
PHASE4
Recruiting
23 participants
Started: Feb 18, 2019 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT03843034
Endometrial Markers in Autoimmune Diseases
N/A
Active, not recruiting
22 participants
Started: Feb 18, 2019 · Completed: Dec 31, 2023
3 conditions
1 sponsor
1 location
NCT03753074
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
PHASE4
Active, not recruiting
780 participants
Started: Feb 18, 2019 · Completed: Dec 31, 2031
1 condition
22 sponsors
10 locations
NCT03648658
Paracetamol Study in Patients With Low Muscle Mass
PHASE4
Recruiting
48 participants
Started: Feb 18, 2019 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT03787355
Clinical Evaluation of Vertical Inter-implant Papilla Height in Platform Matched Implants in Comparison to Morse Connection Abutments
NA
Active, not recruiting
30 participants
Started: Feb 17, 2019 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT03830385
Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck
PHASE2
Recruiting
51 participants
Started: Feb 15, 2019 · Completed: Feb 15, 2026
1 condition
1 sponsor
1 location
NCT03698019
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
PHASE2
Active, not recruiting
313 participants
Started: Feb 15, 2019 · Completed: Oct 31, 2025
4 conditions
1 sponsor
820 locations
NCT03522025
GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs
NA
Active, not recruiting
70 participants
Started: Feb 15, 2019 · Completed: Dec 1, 2026
1 condition
1 sponsor
5 locations
NCT03413384
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
PHASE2
Active, not recruiting
100 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT03672864
Parent Therapist Partnership to Provide Early, Intensive Exercise in Perinatal Stroke
NA
Active, not recruiting
18 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
3 locations
NCT03867539
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
PHASE4
Recruiting
64 participants
Started: Feb 15, 2019 · Completed: Mar 31, 2025
1 condition
2 sponsors
2 locations
NCT03955731
OCT Guided Magmaris RMS in STEMI
NA
Recruiting
100 participants
Started: Feb 15, 2019 · Completed: Feb 15, 2025
1 condition
10 sponsors
1 location
NCT03800823
Overweight and Obesity in Preschoolers
NA
Active, not recruiting
300 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2025
2 conditions
3 sponsors
3 locations
NCT03837782
Outcome of Resection for Colorectal Cancer
NA
Enrolling by invitation
1,300 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2026
1 condition
14 sponsors
1 location
NCT04699305
Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
N/A
Recruiting
500 participants
Started: Feb 14, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT03853447
Fibro-inflammatory Progression From Acute to Chronic Pancreatitis
N/A
Recruiting
150 participants
Started: Feb 14, 2019 · Completed: Jan 1, 2041
6 conditions
1 sponsor
3 locations
NCT03759379
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
PHASE3
Active, not recruiting
164 participants
Started: Feb 14, 2019 · Completed: Oct 29, 2025
2 conditions
1 sponsor
53 locations
NCT03624543
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
PHASE2
Active, not recruiting
51 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT03805022
Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
PHASE3
Recruiting
351 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2028
2 conditions
3 sponsors
10 locations
NCT03765879
Brain Mechanisms of Video-Guided Acupuncture Imagery Treatment on Chronic Low Back Pain
NA
Active, not recruiting
80 participants
Started: Feb 14, 2019 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT04763317
Precision Medicine in the Prostate Cancer Care Pathway
N/A
Recruiting
2,000 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2030
2 conditions
2 sponsors
1 location
NCT03822572
ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer
NA
Active, not recruiting
92 participants
Started: Feb 14, 2019 · Completed: Jan 31, 2028
1 condition
2 sponsors
8 locations
NCT03918798
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
PHASE2
Recruiting
174 participants
Started: Feb 14, 2019 · Completed: Dec 30, 2024
2 conditions
1 sponsor
9 locations
NCT04029181
ImmunoPET With an Anti-CD8 Imaging Agent
PHASE1/PHASE2
Active, not recruiting
47 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT03723473
Spectroscopy in Functional Assessment of Peripheral Artery Disease (spectroAMI)
N/A
Recruiting
40 participants
Started: Feb 13, 2019 · Completed: Apr 30, 2025
1 condition
3 sponsors
1 location
NCT03681535
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
NA
Active, not recruiting
241 participants
Started: Feb 13, 2019 · Completed: Jul 31, 2028
1 condition
1 sponsor
12 locations
NCT03500445
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
PHASE2
Active, not recruiting
75 participants
Started: Feb 13, 2019 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT06737263
Comparison of BioHPP (High Performance Polymer) - vs Titanium- vs Zirconia Abutments
NA
Active, not recruiting
60 participants
Started: Feb 13, 2019 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03694236
Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC
PHASE1/PHASE2
Recruiting
39 participants
Started: Feb 12, 2019 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT04294264
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
PHASE2
Active, not recruiting
50 participants
Started: Feb 12, 2019 · Completed: Mar 27, 2026
6 conditions
2 sponsors
6 locations
NCT03869164
Multi-center Trial of ValveClamp
NA
Recruiting
110 participants
Started: Feb 12, 2019 · Completed: Dec 8, 2025
1 condition
1 sponsor
1 location
NCT03701282
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
PHASE3
Active, not recruiting
720 participants
Started: Feb 12, 2019 · Completed: May 7, 2028
2 conditions
1 sponsor
870 locations
NCT03824275
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
PHASE2/PHASE3
Active, not recruiting
129 participants
Started: Feb 12, 2019 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT03817320
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Feb 12, 2019 · Completed: Jun 30, 2025
3 conditions
3 sponsors
18 locations
NCT04284189
Aftercare of Childhood Cancer Survivors in Switzerland
N/A
Recruiting
140 participants
Started: Feb 12, 2019 · Completed: Aug 31, 2030
3 conditions
3 sponsors
3 locations
NCT03896568
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PHASE1
Recruiting
36 participants
Started: Feb 12, 2019 · Completed: Sep 30, 2027
5 conditions
2 sponsors
1 location
NCT03778060
Long-Term Transcutaneous Stimulation and Essential Tremor: A PET Study
NA
Active, not recruiting
20 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03846167
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
N/A
Active, not recruiting
50 participants
Started: Feb 11, 2019 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT06126159
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
NA
Active, not recruiting
44 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03765983
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
PHASE2
Active, not recruiting
47 participants
Started: Feb 11, 2019 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT03697148
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
NA
Active, not recruiting
852 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
44 locations
NCT03807128
MYeloma Resistance And Clonal Evolution
N/A
Recruiting
1,400 participants
Started: Feb 11, 2019 · Completed: Feb 11, 2049
1 condition
1 sponsor
2 locations
NCT03697408
Itacitinib + Everolimus in Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: Feb 11, 2019 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05197764
Evaluation of Macroscopic Muscle Growth in Infants and Young Children With Spastic Cerebral Palsy
N/A
Recruiting
229 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
Previous
1
More pages
2142
2143
2144
2145
2146
2147
2148
More pages
2369
Next